ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER

被引：0
|
作者：
Kilickap, S. [1 ]
Altun, A. [1 ]
Babacan, N. A. [1 ]
Ataseven, H. [1 ]
Kaya, T. [1 ]
机构：
[1] Cumhuriyet Univ, Fac Med, Sivas, Turkey
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [21] Antitumor and immunomodulatory activity of genkwanin on colorectal cancer in the APCMin/+ mice
    Wang, Xue
    Song, Zi-Jing
    He, Xin
    Zhang, Run-Qi
    Zhang, Chun-Feng
    Li, Fei
    Wang, Chong-Zhi
    Yuan, Chun-Su
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 29 (02) : 701 - 707
  • [22] Critical role of sorafenib exposure over time for its antitumor activity in thyroid cancer
    Bellesoeur, Audrey
    Carton, Edith
    Mir, Olivier
    Groussin, Lionel
    Blanchet, Benoit
    Billemont, Bertrand
    Clerc, Jerome
    Goldwasser, Francois
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (03) : 569 - 572
  • [23] Critical role of sorafenib exposure over time for its antitumor activity in thyroid cancer
    Audrey Bellesoeur
    Edith Carton
    Olivier Mir
    Lionel Groussin
    Benoit Blanchet
    Bertrand Billemont
    Jérôme Clerc
    François Goldwasser
    Investigational New Drugs, 2014, 32 : 569 - 572
  • [24] Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells
    Dkhissi, F
    Lu, H
    Soria, C
    Opolon, P
    Griscelli, F
    Liu, HF
    Khattar, P
    Mishal, Z
    Perricaudet, M
    Li, H
    HUMAN GENE THERAPY, 2003, 14 (10) : 997 - 1008
  • [25] Antitumor activity of sorafenib in osteosarcoma (OS) preclinical models
    Pignochino, Y.
    Grignani, G.
    Cavalloni, G.
    Motta, M.
    Bruno, S.
    Camussi, G.
    Ferrari, S.
    Picci, P.
    Berger, M.
    Aglietta, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Design, synthesis, and antitumor activity of novel sorafenib derivatives
    Hou, Mi
    Zou, Ya-Yu
    Fan, Si-Li
    Li, Xiao-Qin
    Shao, Li-Hui
    Li, Zhu-Rui
    Chen, Dan-Ping
    Wang, Zhen-Chao
    Ouyang, Gui-Ping
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2022, 59 (06) : 1025 - 1035
  • [27] The antiangiogenic tyrosine kinase inhibitor (TKI) sunitinib has direct antitumor activity on renal and colorectal cancer cells in vitro at intratumoral concentrations achieved in mice
    Gotink, Kristy
    Rudek, Michelle
    Broxterman, Henk
    Jaspers, Janneke
    Hammers, Hans
    Peters, Godefridus
    Pili, Roberto
    Verheul, Henk
    CANCER RESEARCH, 2009, 69
  • [28] Antiangiogenic therapy in patients with metastatic colorectal cancer
    Dunst, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 (01) : 66 - 67
  • [29] Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
    Atkins, Charity
    Liu, Qi
    Minthorn, Elisabeth
    Zhang, Shu-Yun
    Figueroa, David J.
    Moss, Katherine
    Stanley, Thomas B.
    Sanders, Brent
    Goetz, Aaron
    Gaul, Nathan
    Choudhry, Anthony E.
    Alsaid, Hasan
    Jucker, Beat M.
    Axten, Jeffrey M.
    Kumar, Rakesh
    CANCER RESEARCH, 2013, 73 (06) : 1993 - 2002
  • [30] Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
    Ceci, Claudia
    Lacal, Pedro M.
    Tentori, Lucio
    De Martino, Maria Gabriella
    Miano, Roberto
    Graziani, Grazia
    NUTRIENTS, 2018, 10 (11)
12345